Clinical biology of the pituitary adenoma

S Melmed, UB Kaiser, MB Lopes, J Bertherat… - Endocrine …, 2022 - academic.oup.com
All endocrine glands are susceptible to neoplastic growth, yet the health consequences of
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …

The 2017 World Health Organization classification of tumors of the pituitary gland: a summary

MBS Lopes - Acta neuropathologica, 2017 - Springer
The 4th edition of the World Health Organization (WHO) classification of endocrine tumors
has been recently released. In this new edition, major changes are recommended in several …

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

G Raverot, P Burman, A McCormack… - European journal of …, 2018 - academic.oup.com
Background Pituitary tumours are common and easily treated by surgery or medical
treatment in most cases. However, a small subset of pituitary tumours does not respond to …

Overview of the 2017 WHO classification of pituitary tumors

O Mete, MB Lopes - Endocrine pathology, 2017 - Springer
This review focuses on discussing the main changes on the upcoming fourth edition of the
WHO Classification of Tumors of the Pituitary Gland emphasizing histopathological and …

The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease

K Hayashi, N Inoshita, K Kawaguchi… - European Journal of …, 2016 - academic.oup.com
Context Somatic mutations in the ubiquitin-specific peptidase USP8 gene were recently
detected in one-to two-third (s) of corticotroph adenomas of Cushing's disease (CD). These …

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours

P Marques, S Barry, E Carlsen, D Collier… - Acta neuropathologica …, 2019 - Springer
Non-tumoural cells within the tumour microenvironment (TME) influence tumour
proliferation, invasiveness and angiogenesis. Little is known about TME in pituitary …

Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care …

S Asioli, A Righi, M Iommi, C Baldovini… - European journal of …, 2019 - academic.oup.com
Objective and design A clinicopathological score has been proposed by Trouillas et al. to
predict the evolution of pituitary adenomas. Aim of our study was to perform an independent …

Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission …

A Mohyeldin, LJ Katznelson, AR Hoffman, K Asmaro… - Scientific Reports, 2022 - nature.com
Recurrence and biochemical remission rates vary widely among different histological
subtypes of pituitary adenoma. In this prospective study, we evaluated 107 consecutive …

The epidemiology of aggressive pituitary tumors (and its challenges)

OM Dekkers, N Karavitaki, AM Pereira - Reviews in Endocrine and …, 2020 - Springer
Pituitary tumors are not rare if prevalence rates from autopsy or radiological series are
considered; approximately 0.5% of all pituitary adenomas will come to medical attention …

Tumor type detection in brain MR images of the deep model developed using hypercolumn technique, attention modules, and residual blocks

M Toğaçar, B Ergen, Z Cömert - Medical & Biological Engineering & …, 2021 - Springer
Brain cancer is a disease caused by the growth of abnormal aggressive cells in the brain
outside of normal cells. Symptoms and diagnosis of brain cancer cases are producing more …